882.45
+1.25(+0.14%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4016
First IPO Date
January 01, 1996
Name | Title | Pay | Year Born |
Mr. Rajeev Nannapaneni | Chief Executive Officer & Vice Chairman | 0 | 1977 |
Dr. Donthineni Linga Rao M.D. | President of Technical Affairs & Whole Time Director | 0 | 1952 |
N. Sadasiva Rao | Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management | 0 | N/A |
Mr. A. Lakshminarayana | Senior Vice President of HR & Organisational Development | 0 | 1963 |
Mr. Chekuri Venkat Ramesh C.S. | Company Secretary & Compliance Officer | 0 | N/A |
Mr. Potluri Sivaramakrishna Prasad | Executive Vice President of Corporate Engineering Services & Whole Time Director | 0 | 1958 |
James Rajakumar | Vice President of Marketing & Sales - Domestic | 0 | N/A |
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. | MD & Chairman | 0 | 1945 |
Nadella Malleswara Rao | Vice President & Head of Operations | 0 | N/A |
Mr. S. V. V. N. Appa Rao | Chief Financial Officer | 0 | N/A |
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.